Table 3.
Prescribed medications among patients with diabetes and hypertension (n = 423).
| Treatment | Categories | Frequency (%) |
|---|---|---|
| Anti-diabetic treatment regimen | OHGA alone | 370 (87.5) |
| OHGA + Insulin | 35 (8.3) | |
| Insulin alone | 18 (4.3) | |
| Specific anti-diabetic medications | Glibenclamide | 14 (3.3) |
| Metformin | 251 (59.3) | |
| Metformin + Glibenclamide | 105 (24.8) | |
| Metformin + Insulin | 35 (8.3) | |
| Anti-hypertensive | Angiotensin-converting enzyme inhibitors | 123 (29.1) |
| Calcium channel blockers | 75 (17.7) | |
| Diuretics | 49 (11.6) | |
| Beta blockers | 25 (5.9) | |
| Combined classes | 151 (35.7) | |
| Other medications | Statins | 257 (60.8) |
| Aspirin | 119 (28.1) | |
| Proton pump inhibitors | 48 (11.3) | |
| Antibiotics | 47 (11.1) | |
| Anti-asthmatics | 17 (4.0) | |
| Othersa | 37 (8.7) | |
| Number of medications per patient | Mean ± SD | 3.57 ± 1.45 |
| Below (<5) | 248 (58.6) | |
| Above (⩾5) | 175 (41.4) |
SD: standard deviation; OHGA: oral hypoglycemic agents.
a
Amitriptyline, carbamazepine, gabapentin, tramadol, and propylthiouracil.